EG21486A - Process for the preparation of 2-amino-n-(1,2 diphenyl-1-methylethyl)-acetamide hydrochloride wich are used as medicament - Google Patents

Process for the preparation of 2-amino-n-(1,2 diphenyl-1-methylethyl)-acetamide hydrochloride wich are used as medicament

Info

Publication number
EG21486A
EG21486A EG133297A EG133297A EG21486A EG 21486 A EG21486 A EG 21486A EG 133297 A EG133297 A EG 133297A EG 133297 A EG133297 A EG 133297A EG 21486 A EG21486 A EG 21486A
Authority
EG
Egypt
Prior art keywords
wich
methylethyl
diphenyl
medicament
amino
Prior art date
Application number
EG133297A
Other languages
English (en)
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Application granted granted Critical
Publication of EG21486A publication Critical patent/EG21486A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/02Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EG133297A 1996-12-19 1997-12-16 Process for the preparation of 2-amino-n-(1,2 diphenyl-1-methylethyl)-acetamide hydrochloride wich are used as medicament EG21486A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9626319.9A GB9626319D0 (en) 1996-12-19 1996-12-19 Synthetic method

Publications (1)

Publication Number Publication Date
EG21486A true EG21486A (en) 2001-11-28

Family

ID=10804657

Family Applications (1)

Application Number Title Priority Date Filing Date
EG133297A EG21486A (en) 1996-12-19 1997-12-16 Process for the preparation of 2-amino-n-(1,2 diphenyl-1-methylethyl)-acetamide hydrochloride wich are used as medicament

Country Status (33)

Country Link
US (1) US6063962A (xx)
EP (1) EP0946497B1 (xx)
JP (1) JP2002512595A (xx)
KR (1) KR100522337B1 (xx)
CN (1) CN1105098C (xx)
AR (1) AR010366A1 (xx)
AT (1) ATE207053T1 (xx)
AU (1) AU725683B2 (xx)
BR (1) BR9713950A (xx)
CA (1) CA2273286A1 (xx)
CZ (1) CZ296780B6 (xx)
DE (1) DE69707503T2 (xx)
DK (1) DK0946497T3 (xx)
EE (1) EE03762B1 (xx)
EG (1) EG21486A (xx)
ES (1) ES2163806T3 (xx)
GB (1) GB9626319D0 (xx)
HU (1) HUP0000420A3 (xx)
ID (1) ID23994A (xx)
IL (1) IL130425A (xx)
IS (1) IS5059A (xx)
MY (1) MY115259A (xx)
NO (1) NO993065D0 (xx)
NZ (1) NZ335870A (xx)
PL (1) PL191196B1 (xx)
PT (1) PT946497E (xx)
RU (1) RU2190597C2 (xx)
SI (1) SI0946497T1 (xx)
SK (1) SK283033B6 (xx)
TR (1) TR199901394T2 (xx)
TW (1) TW415931B (xx)
WO (1) WO1998027052A1 (xx)
ZA (1) ZA9711057B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100826497B1 (ko) 2007-01-22 2008-05-02 삼성전자주식회사 전력 소모를 줄이기 위한 반도체 메모리 장치의 입출력센스 앰프 회로

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE955508C (de) * 1954-07-28 1957-01-03 Cilag Ag Verfahren zur Herstellung von antikonvulsivisch wirkenden Carbonsaeureamiden
IL84305A (en) * 1987-02-06 1992-01-15 Fisons Corp 2-aminoacetamide derivatives

Also Published As

Publication number Publication date
JP2002512595A (ja) 2002-04-23
DK0946497T3 (da) 2001-12-17
ID23994A (id) 2000-06-14
PT946497E (pt) 2002-03-28
ES2163806T3 (es) 2002-02-01
CZ219899A3 (cs) 1999-11-17
SK283033B6 (sk) 2003-02-04
RU2190597C2 (ru) 2002-10-10
CN1105098C (zh) 2003-04-09
GB9626319D0 (en) 1997-02-05
KR20000069552A (ko) 2000-11-25
NO993065L (no) 1999-06-21
EE03762B1 (et) 2002-06-17
DE69707503D1 (de) 2001-11-22
IS5059A (is) 1999-05-28
PL333919A1 (en) 2000-01-31
BR9713950A (pt) 2000-03-21
IL130425A (en) 2003-02-12
PL191196B1 (pl) 2006-03-31
KR100522337B1 (ko) 2005-10-19
EP0946497A1 (en) 1999-10-06
HUP0000420A2 (hu) 2000-08-28
IL130425A0 (en) 2000-06-01
CN1240420A (zh) 2000-01-05
US6063962A (en) 2000-05-16
AU5352498A (en) 1998-07-15
TR199901394T2 (xx) 1999-08-23
ATE207053T1 (de) 2001-11-15
EE9900257A (et) 1999-12-15
CZ296780B6 (cs) 2006-06-14
MY115259A (en) 2003-04-30
NZ335870A (en) 2001-05-25
EP0946497B1 (en) 2001-10-17
AR010366A1 (es) 2000-06-07
CA2273286A1 (en) 1998-06-25
SI0946497T1 (en) 2002-06-30
DE69707503T2 (de) 2002-05-16
HUP0000420A3 (en) 2000-09-28
NO993065D0 (no) 1999-06-21
SK65699A3 (en) 1999-11-08
TW415931B (en) 2000-12-21
WO1998027052A1 (en) 1998-06-25
ZA9711057B (en) 1998-06-19
AU725683B2 (en) 2000-10-19

Similar Documents

Publication Publication Date Title
IL125735A0 (en) Pharmaceutical compositions for the treatment of glaucoma
HU9603495D0 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, as pharmaceutical agents
IL127798A (en) N-substituted indol-3-glyoxylamides, process for their preparation and pharmaceutical compositions comprising them
IL124086A (en) Process for the preparation of 1,1,1,3,3-pentafluoropropane
NO306783B1 (no) Fremgangsmåte for fremstilling av 1-(2'-deoksy-2',2'-difluor-D-ribofuranosyl-4-aminopyrimidin-2-on)hydroklorid
HUP0004664A3 (en) Process for the preparation of acylated cyclic 1,3-dicarbonyl compounds
HK1040980A1 (zh) 聯苯磺酰基氨基氰、其製備方法及其作為藥物的用途
HUP0000960A3 (en) Spray-dried paroxetine hydrochloride, process for it's preparation,use of the compound and pharmaceutical compositions containing the same
IL121730A0 (en) Process for the preparation of 2'-fluoro-5-methyl-beta-L-arabino-furanosyluridine
ZA9811531B (en) Novel process for the preparation of cyclosporin derivatives
HRP980502B1 (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-oles, processes for their preparation and their use as medicaments
EP0692476A3 (de) Verbessertes Verfahren zur Herstellung von N,N'-Carbonyldiazolen, insbesondere N,N'-Carbonyldiimidazol
HUP9600665A2 (en) Substituted benzothienylpiperazines, their use as medicaments, and processes for their preparation
IL139023A0 (en) Process for the preparation of 2,3,5-trimethyl-p- benzoquinone
ZA963019B (en) Process for the preparation of 1,1-difluoroethane
HUP9903852A3 (en) Process for the preparation of contrast agents
EG21486A (en) Process for the preparation of 2-amino-n-(1,2 diphenyl-1-methylethyl)-acetamide hydrochloride wich are used as medicament
IL130831A (en) Imino-aza-anthrayclinone derivatives, process for their preparation and pharmaceutical compositions comprising them for the treatment of amyloidosis
IL120005A (en) Pharmaceutical compositions for the treatment of the eye
EP0690053A3 (de) Verfahren zur Herstellung von 2,5-Dihydrofuran
ZA988397B (en) Process for the preparation of substituted 5,6-dihydro-2H-pyran-2-ones
PH31401A (en) Process for the manufacture of form 1 ranitidine hydrochloride.
HUP0004503A3 (en) Process for the preparation of paroxetine hydrochloride
ZA953682B (en) Process for the manufacture of Form 1 ranitidine hydrochloride
TJ257B (en) Improved process for r/+/-1,2,3,6- tetrahydro-4-phenyl-1-¬(3-phenyl-3- cyclohexen-1-yl)-methyl¾-pyridine or pharmaceutically acceptable salts thereof intermediate substance and process for the preparation thereof